Caloric restriction attenuates Aβ-deposition in Alzheimer transgenic models

Neurobiology of Aging

Volumn 26, Issue 7, 2005, Pages 995-1000

  Patel, Nilay V ^a,d   Gordon, Marcia N ^b   Connor, Karen E ^b   Good, Robert A ^c   Engelman, Robert W ^c   Mason, Jerimiah ^b   Morgan, David G ^b   Morgan, Todd E ^a   Finch, Caleb E ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

AD transgenics; Amyloid deposition; Astrocyte activation; Caloric restriction

Indexed keywords

AGING; ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CALORIC RESTRICTION; CELL ACTIVATION; CONTROLLED STUDY; DIET; DISEASE COURSE; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; TRANSGENIC MOUSE;

EID: 14644421534     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2004.09.014     Document Type: Article

References (36)

1. H. Akiyama, S. Barger, S. Barnum, B. Bradt, J. Bauer, and G.M. Cole Inflammation and Alzheimer's disease Neurobiol Aging 21 2000 383 421
2. N.L. Bodkin, T.M. Alexander, H.K. Ortmeyer, E. Johnson, and B.C. Hansen Mortality and morbidity in laboratory-maintained rhesus monkeys and effects of long-term dietary restriction J Gerontol A Biol Sci Med Sci 58 2003 212 219
3. K.D. Bornemann, K.H. Wiederhold, C. Pauli, F. Ermini, M. Stalder, and L. Schnell Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice Am J Pathol 158 2001 63 73
4. A.J. Bruce-Keller, G. Umberger, R. McFall, and M.P. Mattson Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults Ann Neurol 45 1999 8 15
5. A.G. Cuenca, W.D. Cress, R.A. Good, Y. Marikar, and R.W. Engelman Calorie restriction influences cell cycle protein expression and DNA synthesis during liver regeneration Exp Biol Med (Maywood) 226 2001 1061 1067
6. R.B. DeMattos, J.R. Cirrito, M. Parsadanian, P.C. May, M.A. O'Dell, and J.W. Taylor ApoE and clusterin cooperatively suppress Abeta levels and deposition. Evidence that apoE regulates extracellular abeta metabolism in vivo Neuron 41 2004 193 202
7. C.A. Dickey, J.F. Loring, J. Montgomery, M.N. Gordon, P.S. Eastman, and D. Morgan Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein + presenilin-1 transgenic mice J Neurosci 23 2003 5219 5226
8. M.J. Engelhart, M.I. Geerlings, A. Ruitenberg, J.C. Van Swieten, A. Hofman, and J.C. Witteman Diet and risk of dementia: does fat matter? The Rotterdam Study Neurology 59 2002 1915 1921
9. W. Farris, S. Mansourian, Y. Chang, L. Lindsley, E.A. Eckman, and M.P. Frosch Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo Proc Natl Acad Sci USA 100 2003 4162 4167 Epub 2003, March 12
10. R.P. Friedland, J. Shi, M.A. Smith, G. Perry, and D.L. Sparks Cholesterol feeding enhances cerebral amyloid beta pathology in beagles Neurobiol Aging 25 2004 224
11. M.N. Gordon, L.A. Holcomb, P.T. Jantzen, G. DiCarlo, D. Wilcock, and K.W. Boyett Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1 + APP mouse Exp Neurol 173 2002 183 195
12. W.B. Grant Obesity and Alzheimer disease: roles of diet and genetics Arch Int Med 164 2004 109 110 author reply 110
13. D. Gustafson, E. Rothenberg, K. Blennow, B. Steen, and I. Skoog An 18-year follow-up of overweight and risk of Alzheimer disease Arch Intern Med 163 2003 1524 1528
14. L.K. Heilbronn, and E. Ravussin Calorie restriction and aging: review of the literature and implications for studies in humans Am J Clin Nutr 78 2003 361 369
15. L. Holcomb, M.N. Gordon, E. McGowan, X. Yu, S. Benkovic, and P. Jantzen Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes Nat Med 4 1998 97 100
16. M.H. Laitinen, E-L. Helkala, U. Uusitalo, A. Nissinen, J. Tuomilehto, and H. Soininen Midlife dietary fats and the risk of late-life dementia: a population-based study Neurobiol Aging 25 2004 399
17. C.K. Lee, R. Weindruch, and T.A. Prolla Gene-expression profile of the ageing brain in mice Nat Genet 25 2000 294 297
18. J.A. Luchsinger, M.X. Tang, S. Shea, and R. Mayeux Caloric intake and the risk of Alzheimer disease Arch Neurol 59 2002 1258 1263
19. M.P. Mattson Gene-diet interactions in brain aging and neurodegenerative disorders Ann Intern Med 139 2003 441 444
20. T.E. Morgan, Z. Xie, S. Goldsmith, T. Yoshida, A.S. Lanzrein, and D. Stone The mosaic of brain glial hyperactivity during normal ageing and its attenuation by food restriction Neuroscience 89 1999 687 699
21. R.E. Mrak, and W.S. Griffinbc The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease Neurobiol Aging 22 2001 915 922
22. L. Mucke, E. Masliah, G.Q. Yu, M. Mallory, E.M. Rockenstein, and G. Tatsuno High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation J Neurosci 20 2000 4050 4058
23. N.R. Nichols, J.R. Day, N.J. Laping, S.A. Johnson, and C.E. Finch GFAP mRNA increases with age in rat and human brain Neurobiol Aging 14 1993 421 429
24. A. Olgun, S. Akman, M.A. Serdar, and T. Kutluay Oxidative phosphorylation enzyme complexes in caloric restriction Exp Gerontol 37 2002 639 645
25. N.V. Patel, and C.E. Finch The glucocorticoid paradox of caloric restriction in slowing brain aging Neurobiol Aging 23 2002 707 717
26. G.J. Petot, T. Fritsch, S.M. Debanne, F. Traore, and R.P. Friedland Obesity during the mid-adult years is a rick factor for AD independent of apoE4 genotype Neurobiol Aging 25 2004 305
27. L. Puglielli, R.E. Tanzi, and D.M. Kovacs Alzheimer's disease: the cholesterol connection Nat Neurosci 6 2003 345 351
28. G. Razay, and A. Vreugdenhil AD, abdominal obesity and overweight Neurobiol Aging 25 2004 393
29. L.M. Refolo, B. Malester, J. LaFrancois, T. Bryant-Thomas, R. Wang, and G.S. Tint Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model Neurobiol Dis 7 2000 321 331
30. J. Rogers, R. Strohmeyer, C.J. Kovelowski, and R. Li Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide Glia 40 2002 260 269
31. J.G. Sheng, R.E. Mrak, and W.S. Griffin Enlarged and phagocytic, but not primed, interleukin-1 alpha-immunoreactive microglia increase with age in normal human brain Acta Neuropathol (Berl) 95 1998 229 234
32. F.S. Shie, L.W. Jin, D.G. Cook, J.B. Leverenz, and R.C. LeBoeuf Diet-induced hypercholesterolemia enhances brain A beta accumulation in transgenic mice NeuroReport 13 2002 455 459
33. D.L. Sparks, Y.M. Kuo, A. Roher, T. Martin, and R.J. Lukas Alterations of Alzheimer's disease in the cholesterol-fed rabbit, including vascular inflammation. Preliminary observations Ann N Y Acad Sci 903 2000 335 344
34. T. Tokuda, T. Oide, A. Tamaoka, K. Ishii, S. Matsuno, and S. Ikeda Prednisolone (30-60 mg/day) for diseases other than AD decreases amyloid beta-peptides in CSF Neurology 58 2002 1415 1418
35. G.S. Watson, E.R. Peskind, S. Asthana, K. Purganan, C. Wait, and D. Chapman Insulin increases CSF Abeta42 levels in normal older adults Neurology 60 2003 1899 1903
36. T. Wyss-Coray, J.D. Loike, T.C. Brionne, E. Lu, R. Anankov, and F. Yan Adult mouse astrocytes degrade amyloid-beta in vitro and in situ Nat Med 9 2003 453 457